U.S., Oct. 1 -- An application to own the trademark for 'DELTEX' has been filed on Jan. 03, 2025.
Owner(s):
In8bio, Inc.; 350 Fifth Avenue, Suite 5330, , NEW YORK
Goods and/or Services:
For: Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medica...